Researchers studied eight patients with a rare inherited condition called methylmalonic acidemia (MMA) that makes it hard for their bodies to process certain proteins. The team tested different diet changes and a short-term antibiotic to see what would help most. They found that eating more regular protein and less medical formula, combined with occasional antibiotic treatment, improved the patients’ blood chemistry and reduced harmful waste products in their urine. The study also showed that these changes affected the helpful bacteria living in patients’ stomachs. While this is early research with a small group, it suggests a new approach to managing this serious condition.
The Quick Take
- What they studied: Whether changing what type of protein people with MMA eat, and using a specific antibiotic for short periods, could help their bodies work better and reduce dangerous chemical buildup
- Who participated: Eight patients with confirmed methylmalonic acidemia, a rare genetic disorder that affects how the body breaks down certain amino acids (protein building blocks)
- Key finding: When patients ate more regular food protein and less medical formula, their blood chemistry improved and harmful waste products in their urine decreased. Adding a 10-day course of the antibiotic metronidazole once a month for three months made these improvements even better
- What it means for you: If you or a family member has MMA, this research suggests doctors may have a new tool to help manage the condition better. However, this is early research with a very small group, so talk with your doctor before making any changes to your current treatment plan
The Research Details
This was a prospective longitudinal study, which means researchers followed the same eight patients over time through four different treatment phases. In the first phase, patients ate their regular mixed diet (half regular protein, half medical formula). In phase two, they reduced their protein intake. In phase three, they increased regular protein to 80% of their diet. In phase four, they added a short-term antibiotic called metronidazole taken for 10 days each month for three months.
At each phase, the researchers measured multiple things: the amino acids in patients’ blood, waste products in their urine, the bacteria living in their gut (using advanced DNA testing), and hundreds of different chemicals in their blood and stool. This detailed tracking allowed them to see exactly how each dietary change affected the patients’ bodies.
The study was conducted at a single medical center and included only patients with genetically confirmed MMA, meaning their condition was definitively diagnosed through genetic testing.
Understanding how diet affects MMA is important because this is a serious condition where the body struggles to process certain proteins, leading to toxic buildup. By testing different dietary approaches systematically, researchers can find the safest and most effective way to help patients. The focus on gut bacteria is particularly interesting because emerging science shows that the bacteria in our intestines play a bigger role in our health than previously thought.
This study has both strengths and limitations. Strengths include: detailed genetic confirmation of all participants, measurement of multiple biological markers (not just one outcome), advanced DNA sequencing technology, and systematic tracking through multiple phases. Limitations include: very small sample size (only 8 patients), single center location, and no control group for comparison. The small size means results may not apply to all MMA patients, and individual differences between patients could significantly affect outcomes.
What the Results Show
When patients switched to eating more regular protein (80% of their diet) instead of medical formula, their blood levels of leucine (an amino acid) decreased significantly. This is important because high leucine levels can be problematic in MMA. More importantly, the amount of methylmalonic acid and other harmful waste products in their urine dropped noticeably, suggesting their bodies were processing proteins more efficiently.
When the antibiotic metronidazole was added to the diet plan, the improvements got even better. The harmful waste products in the urine decreased further, indicating that reducing certain gut bacteria helped reduce the toxic buildup in the body. Interestingly, the antibiotic worked even though it killed off some of the helpful bacteria in the gut (a side effect called dysbiosis).
The researchers also discovered that the gut bacteria changed throughout the study. As patients progressed through the different diet phases, the diversity of their gut bacteria decreased, and certain bacteria that produce a helpful substance called butyrate became less common. However, when the antibiotic was added, different bacteria took over, and the overall toxic burden on the body still improved.
The study found that several other waste products decreased with the dietary changes, including 3-hydroxypropionate, lactate, and pyruvate. These are all chemicals that build up when the body can’t properly process certain proteins. The researchers also measured chemicals related to tryptophan metabolism (another amino acid) and found these decreased with antibiotic treatment. These secondary findings all point in the same direction: the combination of dietary changes and short-term antibiotic use helps the body process proteins more efficiently and reduces toxic buildup.
This research builds on earlier studies suggesting that gut bacteria influence how the body handles organic acids (a category that includes MMA). Previous research hinted that diet and gut health were connected in these conditions, but this study is one of the first to systematically test different dietary approaches and measure both the gut bacteria and blood chemistry changes together. The findings support the emerging idea that treating MMA might require attention to both what patients eat and the health of their gut bacteria.
The biggest limitation is the very small sample size of only eight patients. With such a small group, one patient’s unusual response can significantly skew the results. The study also included only patients from one medical center, so the results might not apply to all MMA patients, especially those with different genetic variations of the disease. There was no control group (patients not receiving treatment) for comparison, which makes it harder to know how much improvement came from the treatment versus natural variation. The study was relatively short-term, so we don’t know if these benefits last over months or years. Finally, because MMA is rare, it’s difficult to recruit many patients, which is why the sample size is small.
The Bottom Line
For MMA patients currently managed by a metabolic specialist: This research suggests that a diet emphasizing regular protein (rather than only medical formula) combined with periodic short-term antibiotic therapy may help improve metabolic control. However, confidence in this recommendation is moderate because the study is small and preliminary. Any dietary changes should only be made under close supervision of your metabolic disease specialist, with regular blood and urine testing to monitor safety. For family members and caregivers: This research offers hope that new treatment approaches are being developed, but it’s too early to change current treatment plans based on this single study.
This research is most relevant to: patients with confirmed methylmalonic acidemia and their families, metabolic disease specialists treating MMA patients, and genetic counselors working with MMA families. It may be less relevant to patients with other organic acidemias, though some principles might apply. This research should not be used to guide treatment decisions without consulting with a metabolic disease specialist.
Based on this study, improvements in blood chemistry markers appeared within the timeframe of each dietary phase (weeks to a few months). However, this is a very short-term study, and we don’t know if benefits continue long-term or if the body adapts over time. Realistic expectations would be to see changes in blood and urine markers within weeks to months, but long-term benefits would need to be confirmed with larger, longer studies.
Want to Apply This Research?
- If your doctor approves dietary changes based on this research, track daily protein intake (grams of regular food protein versus medical formula) and record any changes in energy levels, symptoms, or how you feel. Log this weekly along with dates of any antibiotic treatment periods.
- Work with your metabolic dietitian to gradually increase the proportion of regular protein in your diet while decreasing medical formula, monitoring how you feel and waiting for lab results before making further changes. If your doctor prescribes the antibiotic protocol, set reminders for the 10-day treatment periods each month.
- Establish a routine of tracking protein sources at meals, recording any symptoms or changes in how you feel, and maintaining a calendar of lab test dates. Share this information with your metabolic disease team at each visit to help them assess whether the dietary approach is working for your individual situation.
This research describes a small preliminary study in eight patients with a rare genetic condition. These findings should not be used to make changes to any current treatment plan without consulting your metabolic disease specialist or genetic counselor. MMA is a serious condition requiring specialized medical care. Any dietary modifications, including changes to protein intake or medical formula use, must be supervised by a qualified metabolic disease specialist with appropriate laboratory monitoring. This article is for educational purposes only and does not constitute medical advice. Always consult with your healthcare team before making any changes to treatment or diet.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.